Literature DB >> 3284117

Species-specific cyclosporine metabolism.

R Venkataramanan1, C P Wang, K Habucky, R J Ptachcinski, G J Burckart, B Koneru, R Baker, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284117      PMCID: PMC2981406     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Biliary Excretion of Cyclosporine in Liver Transplant Patients.

Authors:  R Venkataramanan; T E Starzl; S Yang; G J Burckart; R J Ptachcinski; B W Shaw; S Iwatsuki; D H Van Thiel; A Sanghvi; H Seltman
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

2.  Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

Authors:  G Maurer; H R Loosli; E Schreier; B Keller
Journal:  Drug Metab Dispos       Date:  1984 Jan-Feb       Impact factor: 3.922

3.  An acid metabolite of cyclosporine.

Authors:  N R Hartman; L A Trimble; J C Vederas; I Jardine
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

4.  Tissue distribution, disposition, and metabolism of cyclosporine in rats.

Authors:  O Wagner; E Schreier; F Heitz; G Maurer
Journal:  Drug Metab Dispos       Date:  1987 May-Jun       Impact factor: 3.922

Review 5.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

6.  Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.

Authors:  R Wassef; Z Cohen; B Langer
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

7.  Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.

Authors:  T G Rosano; B M Freed; J Cerilli; N Lempert
Journal:  Transplantation       Date:  1986-09       Impact factor: 4.939

  7 in total
  7 in total

1.  Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats.

Authors:  S Koehn; F J Frey; R F Speck; T Zeugin; T Schaffner; A Zimmermann; B M Frey
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Mechanism of the ketoconazole-cyclosporin interaction.

Authors:  E Ah-Sing; T W Poole; C Ioannides; L J King
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

4.  Cyclosporin absorption is impaired by the fat substitutes, sucrose polyester and tricarballylate triester, in the rat.

Authors:  K Benmoussa; A Sabouraud; J M Scherrmann; J M Bourre
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

5.  Ocular penetration of cyclosporin A. III: The human eye.

Authors:  D BenEzra; G Maftzir; C de Courten; P Timonen
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

Review 6.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

7.  Effects of Nigella sativa and Lepidium sativum on cyclosporine pharmacokinetics.

Authors:  F I Al-Jenoobi; S A Al-Suwayeh; Iqbal Muzaffar; Mohd Aftab Alam; Khalid M Al-Kharfy; Hesham M Korashy; Abdullah M Al-Mohizea; Abdul Ahad; Mohd Raish
Journal:  Biomed Res Int       Date:  2013-07-16       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.